AIDS Researcher Emerges as Top Candidate to Head CDC

Robert Redfield would replace Brenda Fitzgerald, who resigned in January over unresolved conflicts of interest.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, DANIEL MAYERUpdate (March 21): Redfield was selected to lead the CDC today. He is expected to be sworn in and start as director in just a few days, according to The Washington Post.

Update (March 20): Past allegations of research misconduct by Redfield are resurfacing, Kaiser Health News reports. In 1994, the Army acknowledged accuracy issues with Redfield's HIV vaccine research, but did not reprimand him for misconduct. A whistleblower, who pointed out the issues back then, is now speaking publicly about them and raising concerns about the Trump administration's vetting process.

Robert Redfield, a leading AIDS researcher who works at the University of Maryland School of Medicine, has emerged as the top choice for director of the Centers for Disease Control and Prevention (CDC). He would replace Brenda Fitzgerald who resigned in late January after it was discovered she bought tobacco, pharmaceutical, and health insurance company stock shares early in her tenure as director. President Donald Trump’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Ashley Yeager

    Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo